The ISCCA flow protocol for the monitoring of anti-CD20 therapies in autoimmune disorders.

Arianna GattiFrancesco BuccisanoMaria T ScupoliBruno Brando

Published in: Cytometry. Part B, Clinical cytometry (2020)

The ISCCA Protocol is proposed for a standardized prospective monitoring of patients with autoimmune disorders, to assist the safe and rational usage of anti-CD20 therapies.

Keyphrases

randomized controlled trial
multiple sclerosis
nk cells
drug induced